In a study, Chen et al. demonstrated for the first time that LC3B is an independent predictive biomarker for overall survival and disease-free survival of iCCA, and that high expression of LC3B indicates poor tumor differentiation, early recurrence and short long-term survival [75]. Here, MAP1LC3B is linked to neoplasm.